Please use this identifier to cite or link to this item:
https://etd.cput.ac.za/handle/20.500.11838/2245
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Truter, E.J. | - |
dc.contributor.advisor | Bohm, E. L. J. F. | - |
dc.contributor.author | Serafin, Antonio Mendes | - |
dc.date.accessioned | 2016-06-13T08:27:51Z | - |
dc.date.accessioned | 2016-09-15T09:28:57Z | - |
dc.date.available | 2016-06-13T08:27:51Z | - |
dc.date.available | 2016-09-15T09:28:57Z | - |
dc.date.issued | 2000 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11838/2245 | - |
dc.description | Thesis (MTech (Biomedical Technology))--Cape Technikon, 2011. | en_US |
dc.description.abstract | Cancer of the prostate gland is now recognised as one of the principal medical problems in males. In the USA, cancer of the prostate is the second most commonly diagnosed cancer after skin cancer and the second most common cause of death from cancer after lung cancer. In South Africa, prostate cancer is the second most common cancer, with an estimated annual incidence of 19.1 per LOO000 men (Sitas, 1994). However, this incidence is probably under-estimated, due to incomplete records. Comparison of the incidence of prostate cancer in the different racial groups shows that it is the second most common malignancy in the White, Black (African) and Mixed (Coloured) race groups, and the fourth most common malignancy in Asian (Indian) men in South Africa. Metastatic prostate cancer is refractory to hormone therapy and remains incurable. Hence, novel therapeutic approaches are needed. These anticancer drugs can be tested in tumour cell lines, and cell culture methods also permit testing of optimum conditions. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Cape Technikon | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/za/ | en |
dc.subject | Prostate -- Cancer -- Treatment | en_US |
dc.subject | Cell lines | en_US |
dc.subject | Chemotherapy | en_US |
dc.subject | Apoptosis | en_US |
dc.title | Chemosensitivity of prostatic tumour cell lines under conditions of G2 block abrogation | en_US |
dc.type | Thesis | en_US |
Appears in Collections: | Biomedical Technology - Masters Degrees |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2005566_Serafin_AM_Mtech_Bio_Tech_HWSci_2000_2005566.pdf | Thesis | 21.36 MB | Adobe PDF | ![]() View/Open |
Page view(s)
1,382
Last Week
928
928
Last month
928
928
checked on Feb 16, 2022
Download(s)
75
checked on Feb 16, 2022
Google ScholarTM
Check
This item is licensed under a Creative Commons License